Dr. John Greden to discuss GeneSight study results at upcoming APA annual meeting in May 2018
Nov. 02, 2017 — Myriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive Disorder “From a clinician’s perspective, better but not well is not
Learn more